A Novel YAP1 Inhibitor Targets CSCs-enriched Radiation Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0560
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-resistant Melanomas

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701

Cancer Science
Cancer ResearchMedicineOncology
2020English

Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity

Cancer Research
Cancer ResearchOncology
2013English

Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma

Cancer Research
Cancer ResearchOncology
2013English

The Novel ATM Inhibitor (AZ31) Enhances Antitumor Activity in Patient Derived Xenografts That Are Resistant to Irinotecan Monotherapy

Oncotarget
Oncology
2017English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor

International Journal of Oncology
Cancer ResearchOncology
2014English

Identification and Antitumor Activity of a Novel Inhibitor of the NIMA-related Kinase NEK6

Scientific Reports
Multidisciplinary
2018English

Targeting Cyclin-Dependent Kinase 9 by a Novel Inhibitor Enhances Radiosensitization and Identifies Axl as a Novel Downstream Target in Esophageal Adenocarcinoma

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy